Skip to content
Screener

CapEx at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$71M-20.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.32B+26.7%
Staar Surgical logo
Staar SurgicalSTAA
$443K-69.8%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$60K+9.1%
Ardelyx logo
ArdelyxARDX
$13K-98.0%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$0

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.21B+3.8%
Enterprise value$21.66B-2.1%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Net cash provided by operating activities230211
Cash Flows From Investing Activities
Acquisitions and other investments(12)
Purchases of property, plant and equipment(109)(115)
Acquisition of intangible assets and other assets(38)(9)
Purchases of marketable securities(1)(4)
Proceeds from sale of marketable securities14
Proceeds from sale of assets and businesses, net of costs to sell3

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's capex?
Bausch Health Companies (BHC) reported capex of $109M in Q1 2026.
How has Bausch Health Companies's capex changed year-over-year?
Bausch Health Companies's capex decreased by 5.2% year-over-year, from $115M to $109M.
What is the long-term trend for Bausch Health Companies's capex?
Over 4 years (2021 to 2025), Bausch Health Companies's capex has grown at a 10.2% compound annual growth rate (CAGR), from $269M to $397M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Bausch Health Companies's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude